School of Medicine
Showing 51-56 of 56 Results
Yasuhiro Shudo, MD, PhD
Clinical Assistant Professor, Cardiothoracic Surgery
BioDr. Shudo is a board-certified cardiothoracic surgeon and clinical assistant professor in the Department of Cardiothoracic Surgery at Stanford University School of Medicine.
His clinical focus is the surgical treatment of end-stage cardiopulmonary failure, including heart transplant, heart-lung transplant, lung transplant, mechanical circulatory support (MCS), and extracorporeal membrane oxygenation (ECMO). He has published numerous landmark papers
Dr. Shudo also performs mitral valve repair/replacement (MVR), aortic valve replacement (AVR), complex valve surgery, coronary artery bypass graft (CABG) surgery, reoperative cardiac surgery, minimally invasive surgery, and transcatheter aortic valve replacement (TAVR).
Dr. Shudo is fully committed to innovative, comprehensive, and compassionate care for each patient he treats.
Thelma and Henry Doegler Professor of Cardiovascular Surgery, Emeritus
BioHire date July 1, 1969. Retirement and conferment of Emeritus Professor status September 1, 1998.
Joseph Woo, MD, FACS, FACC, FAHA
Norman E. Shumway Professor, Professor of Cardiothoracic Surgery and, by courtesy, of Bioengineering
BioDr. Woo is a nationally recognized surgeon, innovator, researcher, and educator in cardiothoracic surgery.
He chairs the Stanford Health Cardiothoracic Surgery Department. He is the Norman E. Shumway Professor of Cardiothoracic Surgery and holds a courtesy appointment in the Department of Bioengineering.
Dr. Woo is a board-certified, fellowship-trained heart surgeon with an active clinical practice of more than 300 pump cases per year. He focuses on complex mitral and aortic valve repair, thoracic aortic surgery, cardiopulmonary transplantation, and minimally invasive surgery.
He has advanced these fields by developing innovative surgical procedures. He serves as principal investigator on two studies funded by National Institutes of Health (NIH) grants. One explores stem cells, aniogenesis, tissue engineering, and valvular biomechanics. Dr. Woo has received NIH funding for this study continuously since 2004.
He has served as primary investigator for clinical device trials. He also has been the primary investigator for translational scientific clinical trials entailing administration of stem cells during coronary artery bypass grafting and left ventricular arterial device (LVAD) implantation.
Dr. Woo has co-authored more than 390 articles in peer-reviewed publications.
Dr. Woo serves on the board of directors of the American Association for Thoracic Surgery (AATS). He is the president of the AATS Cardiac Surgery Biology Club. He is a fellow of the American College of Surgeons, American College of Cardiology, and American Heart Association. He serves on the leadership committee of the American Heart Association’s Council on Cardiovascular Surgery and Anesthesia.
He is a member of the Society of Thoracic Surgeons, International Society for Minimally Invasive Cardiac Surgery, International Society for Heart & Lung Transplantation, International Society for Heart Research, and other professional societies.